The Anniston Star21d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...
Managed Healthcare Executive21d
FDA Approves First Biosimilar of Novolog
Like Novolog, Merilog should be administered within five to 10 minutes before eating. Merilog is administered subcutaneously (under the skin). Merilog is expected to be available on the U.S. market in ...
Interesting Engineering21d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin aspart), to enhance glycemic control in adults and children with ...
FiercePharma21d
FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog
NovoLog and Novo Nordisk’s other rapid-acting ... Five months later, the U.S. regulator endorsed Eli Lilly’s version of the drug, called Rezvoglar (insulin glargine-aglr).
Daily22d
Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management
New Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control in adults ...
Medscape22d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for treating adults and children with diabetes.
Finanznachrichten22d
FDA Approves Merilog Rapid-Acting Insulin Biosimilar For Diabetes
PARIS (dpa-AFX) - The U.S. Food and Drug Administration announced ... Merilog has been approved as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and ...
Sierra Sun Times22d
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
February 17, 2025 - Last Friday, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in ...